Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$696M |
| 2 |
AABA
Altaba Inc
AABA
|
+$632M |
| 3 |
AT&T
T
|
+$433M |
| 4 |
Goldman Sachs
GS
|
+$392M |
| 5 |
Walt Disney
DIS
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$938M |
| 5 |
Netflix
NFLX
|
+$423M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.29% |
| 2 | Technology | 1.9% |
| 3 | Financials | 1.28% |
| 4 | Communication Services | 1.02% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Fidelity National Financial
FNF
$12.8B
| $4.23M | ﹤0.01% |
116,939
-4,302
| -4% | -$157K |
|
|
SGYP
2902
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $4.23M | ﹤0.01% |
2,429,670
+506,295
| +26% | +$875K |
|
|
GRMN
2903
CALL
Garmin
GRMN
$55B
| $4.23M | ﹤0.01% |
69,300
-73,600
| -52% | -$4.42M |
|
|
OSG
2904
Octave Specialty Group
OSG
$209M
| $4.22M | ﹤0.01% |
212,810
+54,453
| +34% | +$1.01M |
|
2905
CALL
Carlisle Companies
CSL
$14.2B
| $4.22M | ﹤0.01% |
+39,000
| New | +$4.13M |
|
2906
Vanguard World Funds Extended Duration ETF
EDV
$3.52B
| $4.22M | ﹤0.01% |
36,782
+2,122
| +6% | +$238K |
|
2907
Impinj
PI
$5.2B
| $4.21M | ﹤0.01% |
190,445
+59,014
| +45% | +$999K |
|
|
ASXC
2908
PUT
DELISTED
Asensus Surgical, Inc.
ASXC
| $4.21M | ﹤0.01% |
74,269
+48,931
| +193% | +$1.78M |
|
|
MRTX
2909
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.21M | ﹤0.01% |
85,400
+47,400
| +125% | +$1.79M |
|
2910
CALL
Moelis & Co
MC
$5.07B
| $4.21M | ﹤0.01% |
71,700
+59,700
| +498% | +$3.43M |
|
|
VMRK
2911
CALL
Vivmark Residential
VMRK
$26.1B
| $4.2M | ﹤0.01% |
66,000
+40,900
| +163% | +$2.55M |
|
2912
PUT
Packaging Corp of America
PKG
$21.4B
| $4.19M | ﹤0.01% |
37,500
+12,100
| +48% | +$1.41M |
|
2913
CALL
ANI Pharmaceuticals
ANIP
$1.67B
| $4.19M | ﹤0.01% |
62,700
-21,600
| -26% | -$1.35M |
|
|
JCP
2914
DELISTED
J.C. Penney Company, Inc.
JCP
| $4.19M | ﹤0.01% |
1,789,474
-227,156
| -11% | -$641K |
|
2915
PUT
Arrowhead Research
ARWR
$12B
| $4.19M | ﹤0.01% |
307,800
+147,900
| +92% | +$1.38M |
|
2916
CALL
BorgWarner
BWA
$13.1B
| $4.18M | ﹤0.01% |
110,078
-16,700
| -13% | -$736K |
|
2917
PUT
Texas Capital Bancshares
TCBI
$4.29B
| $4.18M | ﹤0.01% |
45,700
+4,200
| +10% | +$407K |
|
|
PACW
2918
CALL
DELISTED
PacWest Bancorp
PACW
| $4.18M | ﹤0.01% |
84,600
+45,600
| +117% | +$2.38M |
|
|
SOHU
2919
Sohu.com
SOHU
$368M
| $4.18M | ﹤0.01% |
117,670
+62,741
| +114% | +$2.26M |
|
2920
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $4.17M | ﹤0.01% |
133,940
+58,934
| +79% | +$1.84M |
|
2921
CALL
Keysight
KEYS
$54.5B
| $4.17M | ﹤0.01% |
70,700
+42,800
| +153% | +$2.38M |
|
|
SN
2922
DELISTED
Sanchez Energy Corporation
SN
| $4.17M | ﹤0.01% |
921,500
-1,308,531
| -59% | -$4.86M |
|
2923
CALL
HubSpot
HUBS
$13B
| $4.16M | ﹤0.01% |
33,200
-30,800
| -48% | -$3.65M |
|
2924
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $4.16M | ﹤0.01% |
215,790
-30,150
| -12% | -$578K |
|
2925
CALL
Anika Therapeutics
ANIK
$282M
| $4.16M | ﹤0.01% |
129,900
+94,400
| +266% | +$3.89M |
|
Similar funds
Jeff Yass's Q2 2018 Portfolio in Review
As of Q2 2018, Jeff Yass held 11,136 positions worth $291B, up 3.8% from $281B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2018 filing shows 1,911 new, 3,840 increased, 3,666 reduced and 1,619 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M. The largest sale was Meta Platforms (Facebook), an estimated $1.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q2 2018 buy was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $696M increase.
- Jeff Yass's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $1.5B.
- Jeff Yass fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2018, selling an estimated $341M.
- Jeff Yass's ten largest holdings make up 26% of its $291B portfolio in Q2 2018.
- Jeff Yass opened 1,911 new positions and closed 1,619 in Q2 2018.
- Jeff Yass's portfolio value rose 3.8% quarter-over-quarter to $291B.
Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.